Methods of adjustment of antipsychotic treatment of the needs of the individual patients with schizophrenia

被引：0
作者：
Potanin, S. S. [1 ]
Burminsky, D. S. [1 ]
Morozova, M. A. [1 ]
机构：
[1] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 109801, Russia
来源：
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2013年 / 113卷 / 10期
关键词：
schizophrenia; individualization of antipsychotic treatment; pharmacokinetic parameters; selection of antipsychotic drug; TREATMENT-RESISTANT SCHIZOPHRENIA; CLINICALLY IMPORTANT DIFFERENCES; COMBINED PHENOTYPIC ASSESSMENT; RANDOMIZED CONTROLLED-TRIAL; DRUG-METABOLIZING-ENZYMES; QUALITY-OF-LIFE; 1A2; CYP1A2; GENE; CYTOCHROME-P450; MONOZYGOTIC TWINS; ATYPICAL ANTIPSYCHOTICS;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：80 / 87
页数：8
相关论文
共 123 条
[1]   Cytochrome P450 gene polymorphism and cancer [J].
Agúndez, JAG .
CURRENT DRUG METABOLISM, 2004, 5 (03) :211-224
[2]   PREVALENCE OF CYP2D6 GENE DUPLICATION AND ITS REPERCUSSION ON THE OXIDATIVE PHENOTYPE IN A WHITE-POPULATION [J].
AGUNDEZ, JAG ;
LEDESMA, MC ;
LADERO, JM ;
BENITEZ, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (03) :265-269
[3]   Relapse in schizophrenia: costs, clinical outcomes and quality of life [J].
Almond, S ;
Knapp, M ;
Francois, C ;
Toumi, M ;
Brugha, T .
BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 :346-351
[4]   CLOZAPINE-INDUCED AGRANULOCYTOSIS - INCIDENCE AND RISK-FACTORS IN THE UNITED-STATES [J].
ALVIR, JMJ ;
LIEBERMAN, JA ;
SAFFERMAN, AZ ;
SCHWIMMER, JL ;
SCHAAF, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :162-167
[5]  
[Anonymous], 1992, NURSE PRACT, DOI DOI 10.1097/00006205-199211000-00018
[6]  
[Anonymous], 1985, CLIN PSYCHIAT 2, V46, P22
[7]  
[Anonymous], 2013, CURR PHARM DES
[8]  
[Anonymous], 2011, PERS MED, V4, P123
[9]  
[Anonymous], 2011, EUR PSYCHIAT, V26, P3
[10]  
[Anonymous], 1999, THER DRUG MONIT, V21, P474
12345678910